BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ong CY, Low SG, Vasanwala FF, Baikunje S, Low LL. Varicella infections in patients with end stage renal disease: a systematic review. BMC Nephrol 2018;19:185. [PMID: 30041621 DOI: 10.1186/s12882-018-0976-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Hamad MA, Allam H, Sulaiman A, Murali K, Cheikh Hassan HI. Systematic Review and Meta-analysis of Herpes Zoster Vaccine in Patients With CKD. Kidney Int Rep 2021;6:1254-64. [PMID: 34013103 DOI: 10.1016/j.ekir.2021.02.024] [Reference Citation Analysis]
2 Toprak O, Turan OF, Bozyel EA, Alp B, Ucdu GZ. Dialysis-requiring acute kidney injury and electrolyte imbalances as a result of prodromal herpes zoster in a kidney transplant recipient. Transpl Infect Dis 2021;23:e13578. [PMID: 33522083 DOI: 10.1111/tid.13578] [Reference Citation Analysis]
3 Tur-Sinai A, Magnezi R, Grinvald-Fogel H. Assessing the determinants of healthcare expenditures in single-person households. Isr J Health Policy Res 2018;7:48. [PMID: 30318017 DOI: 10.1186/s13584-018-0246-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wen X, Yang L, Sun Z, Zhang X, Zhu X, Zhou W, Hu X, Liu S, Luo P, Cui W. Feasibility of a break-in period of less than 24 hours for urgent start peritoneal dialysis: a multicenter study. Ren Fail 2022;44:450-60. [PMID: 35272577 DOI: 10.1080/0886022X.2022.2049306] [Reference Citation Analysis]
5 Prikhodchenko NG. Varicella-pox virus infection: features of the course, clinical manifestations, complications, and possibilities for prevention. Terapevticheskii arkhiv 2021;93:1401-6. [DOI: 10.26442/00403660.2021.11.201192] [Reference Citation Analysis]
6 Zhang Y, Wang L, Wang Y, Zhang W, Jia N, Xie Z, Huang L, You W, Lu W, Li E, Gao F, Hu Y, Meng F, Xia S. Immunogenicity and Safety of a Booster Dose of Live Attenuated Varicella Vaccine, and Immune Persistence of a Primary Dose for Children Aged 2 to 6 Years. Vaccines 2022;10:660. [DOI: 10.3390/vaccines10050660] [Reference Citation Analysis]